Clinical Trials
2
Active:0
Completed:0
Trial Phases
2 Phases
Phase 1:1
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (50.0%)Phase 1
1 (50.0%)A Study of Pyrotinib Combined With Capecitabine for Metastatic HER-2 Positive Colorectal Cancer
Phase 1
- Conditions
- HER-2 Positive Colorectal Cancer
- Interventions
- First Posted Date
- 2020-01-13
- Last Posted Date
- 2020-01-14
- Lead Sponsor
- Qingdao Zhixin Health Technology Co., Ltd.
- Target Recruit Count
- 34
- Registration Number
- NCT04227041
- Locations
- 🇨🇳
Qingdao University Hospital, Qingdao, Shandong, China
The Individualized Behavioral Intervention of Smartphone App in the Treatment of Type 2 Diabetes Mellitus
Not Applicable
- Conditions
- Diabetes Mellitus, Type 2
- First Posted Date
- 2017-02-23
- Last Posted Date
- 2017-02-23
- Lead Sponsor
- Qingdao Zhixin Health Technology Co., Ltd.
- Target Recruit Count
- 400
- Registration Number
- NCT03061851
- Locations
- 🇨🇳
Qingdao University Hospital, Qingdao, Shandong, China
News
No news found